We also examined whether the PVs/LPVs in the 14 genes of the 18 MBC patients were present at similar frequencies in a cohort of 109 high-risk breast/ovarian cancer women without BRCA1/BRCA2/PALB2 PV/LPV. The gene discussed is PALB2; the disease is ovarian carcinoma.